Pursuant to Regulation 30 and 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') this is to inform ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.1 pts less than Nifty Microcap 250 and 8.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board of Earkart Limited, at its meeting on 11 March 2026, approved two key items: (1) acquisition of land to set up a new manufacturing facility, and (2) acquisition of a pharmaceutical business. No financial details, target name, or deal value were disclosed in this filing. In a separate letter, the company also clarified to BSE that the board meeting was called on shorter notice and the required advance intimation under SEBI's LODR Regulation 29 was not given in time. The company apologized for the delay and attributed it to the urgent nature of the matters, assuring better compliance in the future.
The acquisitions could expand Earkart's manufacturing capacity and add a new pharmaceutical business vertical, which may be positive for long-term growth. However, the late intimation to the exchange is a minor governance red flag and the absence of deal details means investors have limited visibility on size and valuation at this stage.